Published in Curr Pharm Des on January 01, 2007
Topography, cell response, and nerve regeneration. Annu Rev Biomed Eng (2010) 1.70
MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells (2013) 1.51
Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? Br J Pharmacol (2011) 1.28
Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials. Aging Dis (2013) 1.18
Neurorestorative therapy for stroke. Front Hum Neurosci (2014) 1.13
Niacin treatment of stroke increases synaptic plasticity and axon growth in rats. Stroke (2010) 1.07
Synaptic plasticity, neurogenesis, and functional recovery after spinal cord injury. Neuroscientist (2009) 1.06
Translating the frontiers of brain repair to treatments: starting not to break the rules. Neurobiol Dis (2009) 0.97
Treatment of stroke with a synthetic liver X receptor agonist, TO901317, promotes synaptic plasticity and axonal regeneration in mice. J Cereb Blood Flow Metab (2009) 0.97
POSH is an intracellular signal transducer for the axon outgrowth inhibitor Nogo66. J Neurosci (2010) 0.91
Niaspan increases axonal remodeling after stroke in type 1 diabetes rats. Neurobiol Dis (2012) 0.90
Hippocampal expression of myelin-associated inhibitors is induced with age-related cognitive decline and correlates with deficits of spatial learning and memory. J Neurochem (2012) 0.88
Protein folding at the membrane interface, the structure of Nogo-66 requires interactions with a phosphocholine surface. Proc Natl Acad Sci U S A (2010) 0.87
Neurorestorative Therapy of Stroke in Type 2 Diabetes Mellitus Rats Treated With Human Umbilical Cord Blood Cells. Stroke (2015) 0.85
Neutralization of LINGO-1 during in vitro differentiation of neural stem cells results in proliferation of immature neurons. PLoS One (2012) 0.84
Increased hippocampal NgR1 signaling machinery in aged rats with deficits of spatial cognition. Eur J Neurosci (2013) 0.81
Chinese Medicine's Intervention Effect on Nogo-A/NgR. Evid Based Complement Alternat Med (2011) 0.80
Effect of creatine monohydrate supplementation on various hematological and serum biochemical parameters of male albino mice following neonatal hypoxia-ischemia encephalopathy. ScientificWorldJournal (2013) 0.78
Translational spinal cord injury research: preclinical guidelines and challenges. Handb Clin Neurol (2012) 0.78
GSK249320, A Monoclonal Antibody Against the Axon Outgrowth Inhibition Molecule Myelin-Associated Glycoprotein, Improves Outcome of Rodents with Experimental Stroke. J Neurol Exp Neurosci (2016) 0.77
A chemical genetic approach identifies piperazine antipsychotics as promoters of CNS neurite growth on inhibitory substrates. Mol Cell Neurosci (2012) 0.77
Improved neurite outgrowth on central nervous system myelin substrate by siRNA-mediated knockdown of Nogo receptor. Chin J Traumatol (2016) 0.75
Nogo-A expression dynamically varies after spinal cord injury. Neural Regen Res (2015) 0.75
Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients. Stroke (2017) 0.75
Chemical priming for spinal cord injury: a review of the literature. Part I-factors involved. Childs Nerv Syst (2010) 0.75
Polyethylene glycol as a promising synthetic material for repair of spinal cord injury. Neural Regen Res (2017) 0.75
Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol (1987) 1.26
Focal lesions in the rat central nervous system induced by endothelin-1. J Neuropathol Exp Neurol (2003) 1.17
Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand. Br J Pharmacol (1987) 1.09
Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor. J Neurochem (2003) 1.06
Biogenic amine-stimulated cyclic adenosine-3',5'-monophosphate formation in the rat carotid body. J Neurochem (1983) 0.96
Calcium antagonist properties of diclofurime isomers. II. Molecular aspects: allosteric interactions with dihydropyridine recognition sites. J Cardiovasc Pharmacol (1987) 0.90
Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptor. J Med Chem (1988) 0.87
Direct biochemical and neuropharmacological identification of dopamine D2-receptors in the rabbit carotid body. Brain Res (1984) 0.87
Central and peripheral effects of the dihydropyridine calcium channel activator BAY K 8644 in the rat. Eur J Pharmacol (1989) 0.85
Calcium antagonist properties of diclofurime isomers. I. Functional aspects. J Cardiovasc Pharmacol (1987) 0.84
Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam. Br J Pharmacol (1990) 0.82
Catecholamines in the carotid body of several mammalian species: effects of surgical and chemical sympathectomy. Brain Res (1982) 0.80
Biosynthesis of N-acetyldopamine and N-acetyloctopamine by Schistocerca gregaria nervous tissue. J Neurochem (1981) 0.79
Role of the adrenal gland in the metabolic and cardiovascular effects of 8-OH-DPAT in the rat. Eur J Pharmacol (1990) 0.78
Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase. Eur J Pharmacol (1986) 0.77
Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats. Br J Pharmacol (1990) 0.77
Comparison of the cardiovascular effects of trans-diclofurime with different types of calcium antagonists in conscious spontaneously hypertensive rats. Br J Pharmacol (1988) 0.77
MDL 72567, a dihydropyridine calcium-antagonist, that causes vasodilation and direct sinus bradycardia. J Cardiovasc Pharmacol (1987) 0.77
Lactamimides: a novel chemical class of calcium antagonists with diltiazem-like properties. Biochem Pharmacol (1989) 0.76
The effects of dihydropyridine compounds in behavioural tests of dopaminergic activity. Br J Pharmacol (1989) 0.75
Changes in carotid body amine levels and effects of dopamine on respiration in rats treated neonatally with capsaicin. Br J Pharmacol (1984) 0.75
Role of the adrenal medulla in the metabolic and pressor actions of 8-OH-DPAT. Br J Pharmacol (1992) 0.75
Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase. Eur J Pharmacol (1988) 0.75
Differential effects of cromakalim on pancreatic vascular resistance and insulin secretion in vitro. Fundam Clin Pharmacol (1992) 0.75
Increased sensitivity of rabbit carotid body chemoreceptors to dopamine after chronic treatment with domperidone. Eur J Pharmacol (1984) 0.75